Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

PeRsonalised treatmEnts and pain manaGEmeNt for rEpaiR of Aged bone Tissue wIth quantum mOlecular resoNance

Descrizione del progetto

Promuovere la salute delle ossa per una popolazione in fase di invecchiamento

L’invecchiamento delle ossa determina spesso fratture e mobilità ridotta negli anziani, compromettendone la qualità della vita e imponendo notevoli oneri sociali ed economici ai sistemi sanitari. I metodi tradizionali di sperimentazione animale per la comprensione dell’invecchiamento osseo spesso non riescono a rappresentare accuratamente le caratteristiche specifiche degli esseri umani. Sostenuto dal programma di azioni Marie Skłodowska-Curie, il progetto REGENERATION si propone di creare modelli in vitro affidabili e sostenibili di tessuto osseo sano e invecchiato. Istituendo una rete di ricerca in Francia, Grecia, Italia e Svizzera, REGENERATION esplorerà gli effetti generati dalla risonanza molecolare quantistica sulla biologia ossea, nell’ambito di un’iniziativa che formerà inoltre vari scienziati al fine di incrementare le conoscenze sull’invecchiamento osseo, promuovendo terapie personalizzate e migliorando le cure preventive destinate agli anziani.

Obiettivo

REGENERATION aims to build a multidisciplinary research network bringing together complementary expertise in life sciences, bioengineering, medical-device development, computational modelling, artificial intelligence and Quantum Molecular Resonance (QMR) technologies. The project will develop reliable and sustainable in vitro models of healthy and aged bone tissue, treated with or without QMR, and will train a cohort of scientists and technologists in exploiting these models to increase knowledge on bone ageing, mechanobiology, response to physical stimulation and drug-related effects.

Bone ageing reduces the quality of life of elderly people and creates a significant social and economic burden. Ageing bones fail more easily when challenged mechanically or exposed to toxicants or pollutants, and they may respond differently to drugs and physical stimuli compared with healthy bone. To personalise therapies and enable better preventive care for the elderly, it is essential to develop reliable human-based in vitro models of aged bone tissue, reducing dependence on animal models that are costly, ethically sensitive and often unable to capture human-specific features.

REGENERATION will involve 10 active participants from 5 countries: Italy, Greece, Germany, Spain and Switzerland. The consortium brings together universities, research centres and private companies with complementary expertise in cell culture, scaffold optimisation, QMR-based stimulation, dynamic bioreactor culture, microvascularisation, immune-cell interactions, computational modelling, artificial intelligence, bioengineering design and exploitation of biomedical technologies.

The project activities will focus on the development and optimisation of scaffold-based 3D bone models, the use of QMR technology to stimulate and functionalise bone constructs, the integration of vascular and immune-system components to better reproduce relevant in vivo conditions, and the development of computational and data-driven models to support interpretation and optimisation of the experimental results. Dynamic culture systems and advanced culture-device solutions will be used to improve the reproducibility and physiological relevance of the models.

Through international, interdisciplinary and intersectoral staff exchanges, REGENERATION will generate new knowledge on the mechanisms of bone growth, regeneration and ageing, and on the effects of QMR stimuli on cell proliferation, differentiation and transfection. The project will strengthen long-term collaboration between academic and non-academic partners, improve research and innovation capacities across the consortium, and support the development of new tools, protocols and exploitable results in the fields of tissue engineering, regenerative medicine, in vitro testing and biomedical technology.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2022-SE-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

ATHINA-EREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS, TON EPIKOINONION KAI TIS GNOSIS
Contributo netto dell'UE
€ 165 600,00
Indirizzo
ARTEMIDOS 6 KAI EPIDAVROU
151 25 MAROUSSI
Grecia
Regione
Αττική Aττική Κεντρικός Τομέας Αθηνών
Tipo di attività
Research Organisations
Collegamenti
Costo totale
Nessun dato

Partecipanti (9)

Partner (1)